Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
2022-11-29 4:1:53 am Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China GlobeNewsWire
2022-11-26 10:39:49 am Lab Notes: Biotech firm bioMerieux unveils new product for detecting spoiled wine American City Business Journals
2022-11-22 1:1:0 pm Aclaris Therapeutics Announces Key Leadership Transitions GlobeNewswire
2022-11-16 9:10:0 am Aclaris Therapeutics Looks Promising on the Charts
2022-11-10 1:1:0 pm Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences GlobeNewswire
2022-11-08 5:25:1 am Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates Zacks
2022-11-08 4:0:0 am Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update GlobeNewswire
2022-10-26 3:44:48 am We're Hopeful That Aclaris Therapeutics (NASDAQ:ACRS) Will Use Its Cash Wisely Simply Wall St.
2022-09-27 4:0:0 am Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations GlobeNewswire